Fundz

Ratio Therapeutics Appoints Colin Hayward as Chief Medical Officer

PRIVATEMar 12, 2026

Position

Chief Medical Officer

Company

Ratio Therapeutics

Colin Hayward
BostonBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Ratio Therapeutics Inc. announced the appointment of Colin Hayward, MBBS, FFPM, as the company's Chief Medical Officer. Dr

Quick answer

Ratio Therapeutics Appoints Colin Hayward as Chief Medical Officer (March 12, 2026). Ratio Therapeutics is based in Boston, Massachusetts, United States.

Who is the new Chief Medical Officer at Ratio Therapeutics?
Ratio Therapeutics named Colin Hayward Chief Medical Officer, announced March 12, 2026.
What did Ratio Therapeutics announce on March 12, 2026?
Ratio Therapeutics Inc. announced the appointment of Colin Hayward, MBBS, FFPM, as the company's Chief Medical Officer.
What does Ratio Therapeutics do?
Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment...
Where is Ratio Therapeutics based?
Ratio Therapeutics is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
MBX Biosciences, Inc. (March 10, 2026), Santhera Pharmaceuticals (March 10, 2026), Alchemab Therapeutics (March 17, 2026) and Atossa Therapeutics (March 19, 2026) also announced leadership changes within 45 days of Ratio Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ratio Therapeutics, and when

A new leader at Ratio Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ratio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ratio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ratio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ratio Therapeutics

Location

1 617-371-8898 One Design Center

Boston, Massachusetts, United States

About

Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. With headquarters and laboratories in Boston, the company currently employs a growing team of multidisciplinary experts with backgrounds in radiopharmaceutical discovery and development. Ratio's proprietary R&D platforms, Trillium™ and Macropa™, enable the development of fit-for-purpose radiopharmaceuticals for therapy and imaging that possess pharmacokinetic modulation, thereby improving drug availability, tumor delivery, and tumor loading. The company maintains a strong commitment to manufacturing through its collaboration with PharmaLogic and its own state-of-the-art facility located in Salt Lake City, Utah, ensuring reliable supply and quality in radiopharmaceutical production. Ratio plans to initiate a Phase 1/2 trial to evaluate the safety, tolerability and efficacy of its FAP-targeted radiotherapeutic as a treatment for patients with relapsed or refractory soft tissue sarcoma. The company is also advancing other programs in its pipeline, including the pre-clinical assessment of [Lu-177]-RTX2358 across several cancer indications to explore its broader therapeutic potential and expects its Granzyme B-targeted agent for PET imaging program to move into the clinic in 2026.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ratio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jack
Likely contact at this company
••••••••@••••••••

See Jack's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Ratio Therapeutics's next move

Learn about Strategic plan

Ratio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.